Cargando…
COVID-19 and the role of chronic inflammation in patients with obesity
Coronavirus disease 2019 (COVID-19) and the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a particular risk to people living with preexisting conditions that impair immune response or amplify pro-inflammatory response. Low-grade chronic systemic inflammation, common in p...
Autores principales: | Chiappetta, Sonja, Sharma, Arya M., Bottino, Vincenzo, Stier, Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224343/ https://www.ncbi.nlm.nih.gov/pubmed/32409680 http://dx.doi.org/10.1038/s41366-020-0597-4 |
Ejemplares similares
-
Letter to the Editor: Intragastric Balloon Removal During the COVID-19 Pandemic: to Postpone or Not? That Is the Question
por: Chiappetta, Sonja, et al.
Publicado: (2020) -
A case report: Liraglutide as a novel treatment option in late dumping syndrome
por: Chiappetta, Sonja, et al.
Publicado: (2017) -
The role of COVID-19 in prostate tissue inflammation: first pathological evidence
por: Pecoraro, Alessio, et al.
Publicado: (2022) -
Are adipokines the missing link between obesity, immune response, and outcomes in severe COVID-19?
por: Blot, Mathieu, et al.
Publicado: (2021) -
Metabolic syndrome and extensive adipose tissue inflammation in morbidly obese Göttingen minipigs
por: Renner, Simone, et al.
Publicado: (2018)